FDA Commissioner Scott Gottlieb, once a critic of drug importation, is now tasked with the challenge of figuring out whether bringing certain low-cost drugs in from overseas will provide price relief for consumers.
FDA Commissioner Scott Gottlieb, once a critic of drug importation, is now tasked with the challenge of figuring out whether bringing certain low-cost drugs in from overseas will provide price relief for consumers.